期刊文献+

白介素8在肺癌中的作用 被引量:2

Role of interleukin-8 in lung cancer
原文传递
导出
摘要 白介素8(IL-8)近来被认为是一种肿瘤血管生成和促肿瘤细胞生长因子,其在肺癌中也有相当重要的作用。肺癌患者血清和肿瘤组织中的IL-8高水平可能和预后差相关。目前,肺癌细胞和炎症细胞都已被证明可以生成IL-8。而IL-8表达的分子机制主要包括核因子κB和促分裂原活化蛋白激酶通道。另外,有研究发现,IL-8的分泌活化在肺癌的治疗中是一种普遍的现象,有可能导致肺癌治疗失败和肿瘤耐药。因此,以IL-8为靶点,可能是针对肺癌的一种可替代的临床治疗手段。 Interleukin-8 (IL-8)has been proposed to play a crucial role in the angiogenesis and growth of tumor,including lung cancer. High level of IL-8 in both serum and lung cancer tissue may be correlated with the poor prognosis of disease. The secretion of IL-8 is derived from both tumor cells and inflammatory cells. The molecular mechanism of IL-8 expression might be closely associated with nuclear factor-κB and mitogen-activated protein kinase pathway. Other studies have suggested that the secretion and activation of IL-8 are common in the treatment of lung cancer, might lead to treatment failure and drug resistance of lung eancer. Thus, targeting IL-8 in lung cancer treatment might be an alternative clinical therapy.
作者 张勇 王向东
出处 《国际呼吸杂志》 2010年第4期208-212,共5页 International Journal of Respiration
基金 上海市重点学科建设项目(B115) 复旦大学(杰出教授基金)和上海市科学技术委员会资助项目(08PJ1402900)
关键词 白介素8 趋化因子受体 肺癌 治疗 Interleukin-8 Chemokine receptor Lung cancer Therapy
  • 相关文献

参考文献52

  • 1Jemal A,Siegel R,Ward E,et al.Cancer statistics,2007.CA Cancer J Clin,2007,57:43-66.
  • 2Parkin DM,Bray F,Ferlay J,et al.Global cancer statistics,2002.CA Cancer J Clin,2005,55:74-108.
  • 3Toh CK.The changing epidemiology of lung cancer.Methods Mol Biol,2009.472:397-411.
  • 4Koch AE,Polverini PJ,Kunkel SL,et al.Interleukin-8 as a maerophage-derived mediator of angiogenesis.Science,1992,258:1798-1801.
  • 5Rofstad EK.Halsφr EF.Vascular endothelial growth factor,interleukin 8,platelet-derived endothelial cell growth factor,and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.Cancer Res,2000,60:4932-4938.
  • 6De Lareo JE,Wuertz BR,Rosner KA,et al.A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells.Am J Pathol,2001,158:639-646.
  • 7Selabas GM,Fujioka S,Schmidt C,et al.Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells.Clin Cancer Res,2005,11:440-449.
  • 8Masuya D,Huang C,Liu D,et al.The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients.Cancer,2001,92:2628-2638.
  • 9Boldrini L,Gisfredi S,Ursino S.et al.Interleukin-8 in nonsmall cell lung carcinoma:relation with angiogenic pattern and p53 alterations.Lung Cancer,2005,50:309-317.
  • 10Yuan A,Yang PC,Yu CJ,et al.Interleukin-8 messenger ribonueleicacidexpressioncorrelateswithtumor progression,tumor angiogenesis,patient survival,and timing of relapse in non-small-cell lung cancer.Am J Respir Crit Care Med,2000,162:1957-1963.

同被引文献24

  • 1梁东风,黄烽.抗TNF-α疗法治疗银屑病关节炎和银屑病[J].中国药物应用与监测,2005,2(3):39-42. 被引量:6
  • 2丁国民.肺癌患者血清中TNF、IL-8水平的变化及意义[J].淮海医药,2004,22(4):269-270. 被引量:4
  • 3Bowes J, Ho P, Flynn E, et al. Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psori- atic arthritis cohort[J].Ann Rheum Dis, 2012,71 (8): 1350-1354.
  • 4Menter A, Gottlieb A, Feldman SR, et al. Guidelines of care for the management of psoriasis and psoriatic arthri- tis:Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics[J]. J Am Acad Dermatol, 2008,58 ( 5 ) : 826-850.
  • 5Brockbank JE, Stein M, Schentag CT, et al. Dactylitis in psoriatic arthritis:a marker for disease severity[J].Ann Rheum Dis,2005,64(2) :188-190.
  • 6Mease P. TNF-a therapy in psoriatic arthritis and psoria- sis:how and why does it work[J]. Ann Rheum Dis,2004, 63(7) :755-758.
  • 7Paliogiannis P, Attene F, Cossu A, et al. Lung cancer epidemiology in North Sardinia, Italy [J]. Multidiscip Respir Med, 2013,8 (1) :45.
  • 8Zhang Y, Yang D, Weng L, et al. Early lung cancer diagnosis by biosensors[J]. Int J Mol Sci, 2013,14(8) :15479-15509.
  • 9Smith DR, Polverini PJ, Kunkel SL, et al. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma [J]. J Exp Med, 1994,179(5) :1409-1415.
  • 10Boldrini L, Gisfredi S, Ursino S, et al. Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations[J]. Lung Cancer, 2005 ,50( 3) :309-317.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部